ATARA BIOTHERAPEUTICS, INC. (ATRA) Total liabilities 2022–2025
ATARA BIOTHERAPEUTICS, INC. (ATRA) total liabilities at each fiscal year-end, per SEC filings.
$58.7MFY2025 · since FY2022: $249.8M → $58.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $58.7M | -71.5% |
| FY2024 | $206.4M | -22.0% |
| FY2023 | $264.7M | +6.0% |
| FY2022 | $249.8M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More ATRA financial trends
ATRA RevenueATRA Net incomeATRA Net marginATRA Gross profitATRA Gross marginATRA Operating incomeATRA Operating marginATRA Operating cash flowATRA Free cash flowATRA Capital expendituresATRA Return on equityATRA Stock buybacksATRA Dividends paidATRA Total assetsATRA Shareholders’ equityATRA overview →